Clinical Trial Update: A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 study comparing Sarpogrelate sustained-release plus aspirin versus aspirin alone on blood viscosity in patients with peripheral arterial disease and c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Peripheral Arterial Disease

Drugs mentioned

• Aspirin (Aspirin)
• Sarpogrelate (sarpogrelate)

Snippet

Sponsor: Yuhan Corporation | Conditions: Sarpogrelate, Blood Viscosity | Phase 4 | Status: COMPLETED